Spanish Lung Liquid vs. Invasive Biopsy Program (SLLIP)

CompletedOBSERVATIONAL
Enrollment

186

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

January 31, 2019

Conditions
Lung Cancer
Interventions
DIAGNOSTIC_TEST

Guardant360

Cell-free circulating tumor DNA (cfDNA) targeted next-generation sequencing (NGS) panel.

Trial Locations (7)

Unknown

H. Can Ruti, Badalona

Dexeus, Barcelona

H. del Mar, Barcelona

H. Sant Pau, Barcelona

H. Vall Hebrón, Barcelona

ICO Bellvitge, L'Hospitalet de Llobregat

H. Arnau de Vilanova, Valencia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Guardant Health, Inc.

INDUSTRY

lead

MedSIR

OTHER